Low serum testosterone and increased diastolic ocular perfusion pressure: A risk for retinal microvasculature

Vasa - European Journal of Vascular Medicine

Volumn 44, Issue 6, 2015, Pages 435-443

  Malan, Nico T ^a   Smith, Wayne ^a   von Känel, Roland ^c   Hamer, Mark ^b   Schutte, Alta E ^a   Malan, Leoné ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c North West University ^*

Author keywords

Diastolic ocular perfusion pressure; Intraocular pressure; Pulse pressure; Retinal microvascular calibre; Testosterone

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR PROCEDURE; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; RETINA BLOOD VESSEL; SENSITIVITY ANALYSIS; TESTOSTERONE BLOOD LEVEL; BLACK PERSON; BLOOD; BLOOD PRESSURE; CAUCASIAN; DEFICIENCY; EPIDEMIOLOGY; ETHNOLOGY; MICROCIRCULATION; MICROVASCULATURE; MIDDLE AGED; OCULAR HYPERTENSION; PATHOPHYSIOLOGY; PROTECTION; RETINAL NEOVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; SOUTH AFRICA; VASCULAR RESISTANCE; VASODILATATION;

TESTOSTERONE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MICROCIRCULATION; MICROVESSELS; MIDDLE AGED; OCULAR HYPERTENSION; PROTECTIVE FACTORS; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; RISK ASSESSMENT; RISK FACTORS; SOUTH AFRICA; TESTOSTERONE; VASCULAR RESISTANCE; VASODILATION;

EID: 84946849173     PISSN: 03011526     EISSN: 16642872     Source Type: Journal    
DOI: 10.1024/0301-1526/a000466     Document Type: Article

References (30)

1. Jones TH. Testosterone deficiency: a risk factor for cardiovascular disease? Trends Endocrinol Metab 2010; 21: 496-503.
2. Toker E, Yenice Ö, Akpinar, I, et al. Influence of serum levels of sex hormones on intraocular pressure in menopausal women. J Glaucoma 2003; 12: 436-440.
3. Malan NT, Hamer M, Schutte AE, et al. Low testosterone and hyperkinetic blood pressure responses in a cohort of South African men: the SABPA study. Clin Exp Hypertens 2012; 35: 228-235.
4. Malan NT, Hamer M, Lambert GW, et al. Sex hormones associated with subclinical kidney damage and atherosclerosis in South African men: the SABPA study. J Hypertens 2012; 30: 2387-2394.
5. Kawasaki R, Cheung N, Wang JJ, et al. Retinal vessel diameters and risk of hypertension: the Multi-ethnic Study of Atherosclerosis. J Hypertens 2009; 27: 2386-2393.
6. Henderson AD, Bruce BB, Newman NJ, et al. Hypertension-related eye abnormalities and the risk of stroke. Rev Neurol Dis 2011; 8: 1-9.
7. Yanagi M, Kawasaki R, Wang JJ, et al. Vascular risk factors in glaucoma: a review. Clin Exp Ophthalmol 2011; 39: 252-258.
8. Quaranta L, Gandolfo F, Turano R, et al. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma. Invest Ophthalmol Vis Sci 2006; 47: 2917-2923.
9. Jürgens C, Grossjohann R, Tost FHW. Relationship of systemic blood pressure with ocular perfusion pressure and intraocular pressure of glaucoma patients in telemedical monitoring. Med Sci Monit 2012; 18: MT85-89.
10. Corona G, Manucci E, Lotti F, et al. Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED. J Sex Med 2009; 6: 285-293.
11. Puttabyatappa Y, Stallone JN, Ergul A, et al. Peroxynitrite mediates testosteroneinduced vasodilation of microvascular resistance vessels. J Pharmacol Exp Ther 2013; 345: 7-14.
12. Malan L, Hamer M, Frasure-Smith N, et al. COHORT PROFILE: Sympathetic activity and Ambulatory Blood Pressure in Africans (SABPA) Prospective Cohort Study. Int J Epidem 2014. doi: 10.1093/ije/dyu199.
13. Opie LH, Seedat YK. Hypertension in Sub-Saharan populations. Circulation 2005; 112: 3562-3568.
14. Jarvis MJ, Feyerabend C, Bryant A, et al. Passive smoking in the home: plasma cotinine concentrations in non-smokers with smoking partners. Tob Control 2001; 10: 368-74.
15. Zielinska-Danch W, Wardas W, Sobczak A, Szoltysek-Boldys I. Estimation of urinary cotinine cut-offpoints distinguishing non-smokers, passive smokers and active smokers. Biomarkers; 12 (5): 484-496.
16. Zatu MC, van Rooyen JM, Loots du T, et al. A comparison of the cardiometabolic profile of black South Africans with suspected non-alcoholic fatty liver disease (NAFLD) and excessive alcohol use. Alcohol 2015; 49 (2): 165-72.
17. Mosteller RD. Simplified calculation of body-surface area. N Eng J Med 1987; 317: 1098.
18. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-1357.
19. Hayman DM, Xiao Y, Yao Q, et al. Alterations in pulse pressure affect artery function. Cell Mol Bioeng 2012; 5: 474-487.
20. Patel V, Sailesh S, Panja S, et al. Retinal perfusion pressure and pulse pressure: clinical parameters predicting progression to sight-threatening diabetic retinopathy. Br J Diabetes Vasc Dis 2001; 1: 80-87.
21. Knudtson MD, Lee KE, Hubbard LD, et al. Revised formulas for summarizing retinal vessel diameters. Curr Eye Res 2003; 27: 143-149.
22. Vermeulen A, Verdonck L & Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrin Metab; 84 (10): 3666-3672
23. Nguyen TT, Wang JJ, Sharrett AR, et al. Relationship of retinal vascular calibre with diabetes and retinopathy. Diabetes Care 2008; 31: 544-549.
24. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and compared indirect effects in multiple mediator models. Behav Res Methods 2008; 40 (3): 879-891
25. Cherecheanu AP, Garhofer G, Schmidl D, et al. Ocular perfusion pressure and ocular blood flow in glaucoma. Curr Opin Pharmacol 2013; 13: 36-42
26. st Ed. Ed: Schmetterer L, Kiel JW. 2012:173-184. Springer Verlag, Berlin Heidelberg.
27. Flammer, J.;Konieczka, K.;Flammer, A.J.; The primary vascular dysregulation syndrome: implications for eye diseases. EPMA Journal 2013;4:14. doi:10.1186/1878-5085-4-14.
28. Schmidl D, Schmetterer L, Garhöfer G, et al. Gender differences in ocular blood flow. Current Eye Res 2015; 40 (2): 201-212.
29. Kelly DM, Jones TH. Testosterone: a vascular hormone in health and disease. J Endocrinol 2013; 217: R47-R71.
30. Moore D, Harris A, WuDunn D. Dysfunctional ocular blood flow: a risk factor for glaucoma? Clin Ophthalmol 2008; 2 (4): 849-861.